During the past decade, Neurology Associates P.C. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurology Associates P.C." #1 sponsor was "Cytokinetics" with 5 trials, followed by "Mitsubishi Tanabe Pharma America Inc." with 5 trials sponsored, "Avanir Pharmaceuticals" with 4 trials sponsored, "Knopp Biosciences" with 2 trials sponsored and "Amylyx Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Associates P.C." #1 collaborator was "ALS Association" with 3 trials as a collaborator, "ALS Finding a Cure" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Ionis Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Neurology Associates P.C." are "Amyotrophic Lateral Sclerosis" (12 trials), "ALS" (4 trials), "Amyotrophic Lateral Sclerosis (ALS)" (3 trials), "Multiple Sclerosis" (3 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Neurology Associates P.C." in a lesser frequency.

Most popular intervention types in "Neurology Associates P.C." are "Drug" (22 trials), "Other" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "MT-1186" (4 trials), "Reldesemtiv" (3 trials), "AVP-923" (2 trials) and "Dexpramipexole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Neurology Associates P.C." are 24 trials for "All" genders.

Currently, there are NaN active trials in "Neurology Associates P.C.". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Neurology Associates P.C., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Neurology Associates P.C., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".